TCL Archive Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says February 19, 1993
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Senate Committee Ok’s $1.9 Billion Budget For NCI, Same As House Appropriation July 29, 1994
